Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
about
An update on dual Src/Abl inhibitors.Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.Opening the door to the development of novel Abl kinase inhibitors.Novel 1,5-diphenyl-6-substituted 1H-pyrazolo[3,4-d]pyrimidin-4(5H)-ones induced apoptosis in RKO colon cancer cells.SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.Probing the binding site of abl tyrosine kinase using in situ click chemistry.Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors.Dipyrazolo[1,5-a:4',3'-c]pyridines - a new heterocyclic system accessed via multicomponent reaction.The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells.Water Solubility Enhancement of Pyrazolo[3,4-d]pyrimidine Derivatives via Miniaturized Polymer-Drug Microarrays.Theoretical Studies on Pyrazolo[3,4-d]pyrimidine Derivatives as Potent Dual c-Src/Abl Inhibitors Using 3D-QSAR and Docking Approaches.Synthesis and Tautomerism of Substituted Pyrazolo[4,3-c]pyrazoles
P2860
Q34270677-2BB52758-9254-42DA-B224-F0D7CC36B54AQ34787546-7A1817F8-90C2-467F-B56A-1457B91C0FCBQ38806783-7F6B4272-6B22-46C2-975F-15773CAC21E1Q38811039-0CD2A5C6-AFA5-437F-A53F-F35349DCBA57Q38927421-FE342DC9-217F-43F3-B07B-B2F8F0527B39Q39778716-92491B9B-C160-4C54-9DC6-217BAAA39109Q39780179-06C9AB0C-8EE9-424A-B0FF-D2D0C7ADCDBFQ41932682-168D17AE-BC26-4933-9E2A-BE586B9D4B9FQ48263188-77F6A250-E974-46BE-BBE7-ACE41C423053Q52655078-41738A60-94AD-4253-A0DC-C2CCE4E47C25Q53611498-AC0463D0-170C-4B03-86FE-4B5067019934Q57744813-0B1EFC12-0BAB-462B-A461-72D05A664B76
P2860
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Design, synthesis, biological ...... ls: a lead optimization study.
@ast
Design, synthesis, biological ...... ls: a lead optimization study.
@en
type
label
Design, synthesis, biological ...... ls: a lead optimization study.
@ast
Design, synthesis, biological ...... ls: a lead optimization study.
@en
prefLabel
Design, synthesis, biological ...... ls: a lead optimization study.
@ast
Design, synthesis, biological ...... ls: a lead optimization study.
@en
P2093
P50
P356
P1476
Design, synthesis, biological ...... lls: a lead optimization study
@en
P2093
Chiara Brullo
Claudio Zamperini
Cristina Tintori
Francesca Musumeci
Giovanni Maga
Henry Daigl
Maurizio Botta
Silvia Schenone
Vincenzo Bernardo
P304
P356
10.1021/JM1012819
P407
P577
2011-03-28T00:00:00Z